Tecnalia’s genetics laboratory, committed to the fight against cancer

8 February 2024
4 febrero Dia mundial contra el cáncerancer

“Together we can make a difference in the prevention and treatment of cancer”

February 4 is World Cancer Day, advocating “for fairer care”

As every year, Tecnalia joins the global crusade led by the Union for International Cancer Control to commemorate World Cancer Day. TECNALIA’s Genetics Laboratory is committed to the fight against this disease that affects so many lives. We know that early detection and risk assessment are key, which is why TECNALIA offers oncology clinics and professionals the identification of specific genetic biomarkers for early diagnosis, prediction of disease progression and, especially, screening of patients to give them specific therapies. This last group of genetic biomarkers is extremely important, as they will make it possible to select the most suitable therapeutic option according to the molecular characteristics of the tumour, thereby making the selected therapy more effective against the disease. As a CDMO (Contract Development and Manufacturing Organisation), TECNALIA also channels its commitment to the fight against cancer through drug research, with the aim of offering innovative solutions and contributing to significant advances in therapies. We know that each of us has the ability to make a difference to a greater or lesser extent, and that together we can make real progress in reducing the global impact of cancer.

TECNALIA is committed to the fight against cancer

According to the projections in the report “Las cifras del cáncer en España 2024” (Cancer figures in Spain 2024), prepared by SEOM and REDECAN for World Cancer Day, the number of cases diagnosed in Spain is expected to reach 286,664 during the year. This reflects a slight increase of 2.6% compared to 2023. The commemoration of this day serves not only as an occasion to carry out a detailed assessment of current statistics, but also to highlight the importance of hope as a result of advances in research. It is also an opportunity to review areas that require further attention and address future challenges in the fight against cancer. In line with these objectives, the Spanish Society of Medical Oncology (SEOM) has highlighted its priorities for 2024. These goals include the continued promotion of research, the promotion of quality care and the defence of equity in terms of access to a wide range of therapeutic options. This includes not only innovative medicines, but also the latest advances in precision medicine treatments, ensuring their availability to all patients nationwide. Emphasis has also been placed on promoting multidisciplinary, humanised care, with a particular focus on the emotional care of patients. The day is aimed at raising global awareness, improving education and galvanising personal and group action.